Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial

BACKGROUND: This study aimed to evaluate whether fluvoxamine reduces clinical deterioration in adult patients with mild to moderate coronavirus disease 2019 (COVID-19), and to identify risk factors for clinical deterioration in patients admitted to a community treatment center (CTC). MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Hyeonji, Kim, Haein, Bae, Seongman, Park, Seonghee, Chung, Hyemin, Sung, Heung-sup, Jung, Jiwon, Kim, Min Jae, Kim, Sung-Han, Lee, Sang-Oh, Choi, Sang-Ho, Kim, Yang Soo, Son, Ki Young, Chong, Yong Pil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987178/
https://www.ncbi.nlm.nih.gov/pubmed/35384422
http://dx.doi.org/10.3947/ic.2021.0142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987178/
https://www.ncbi.nlm.nih.gov/pubmed/35384422
http://dx.doi.org/10.3947/ic.2021.0142

Ejemplares similares